Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Hanlim Pharmaceutical

02 4MS Pharma

03 3Zota Healthcare Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Brand Name : HANLIM AMISULPIRIDE

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging : 100T

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Korea

blank

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Dosage : TABLET

Dosage Strength : 100MG

Brand Name : HANLIM AMISULPIRIDE

Approval Date :

Application Number :

Registration Country : South Korea

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Brand Name : HANLIM AMISULPIRIDE

Dosage Form : TABLET

Dosage Strength : 200MG

Packaging : 100T

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Korea

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Dosage : TABLET

Dosage Strength : 200MG

Brand Name : HANLIM AMISULPIRIDE

Approval Date :

Application Number :

Registration Country : South Korea

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Brand Name : HANLIM AMISULPIRIDE

Dosage Form : TABLET

Dosage Strength : 400MG

Packaging : 100T

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Korea

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Dosage : TABLET

Dosage Strength : 400MG

Brand Name : HANLIM AMISULPIRIDE

Approval Date :

Application Number :

Registration Country : South Korea

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Brand Name :

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic CTD, BE- Available

Registration Country : Jordan

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Dosage : TABLET

Dosage Strength : 50MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Jordan

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Brand Name :

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic CTD, BE- Available

Registration Country : Jordan

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Dosage : TABLET

Dosage Strength : 100MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Jordan

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Brand Name :

Dosage Form : TABLET

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic CTD, BE- Available

Registration Country : Jordan

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Dosage : TABLET

Dosage Strength : 200MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Jordan

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Brand Name :

Dosage Form : TABLET

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic CTD, BE- Available

Registration Country : Jordan

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Dosage : TABLET

Dosage Strength : 400MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Jordan

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Brand Name :

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Dosage : TABLET

Dosage Strength : 50MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Brand Name :

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Dosage : TABLET

Dosage Strength : 100MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Brand Name :

Dosage Form : TABLET

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sultopride

Dosage : TABLET

Dosage Strength : 200MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank